Blue Therapeutics
Waltham
About Blue Therapeutics
Blue Therapeutics was founded in 2015 by Ajay Yekkirala, David Roberson, Michio Painter and academic founder Phil Portoghese. Blue was born out of the desire to take decades of knowledge and technology from academic research and transform that work into therapeutic solutions that can have positive and lasting impacts for patients in the clinic. Working in New England where the opioid epidemic has struck particularly hard, this meant asking theirselves why better therapeutic options for pain don't exist.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $100.0K
- Last round: Grant (Jan 2020)
- Website: bluetherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/blue-therapeutics-139490 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.